Patent ID: 11896660
Assignee: SEQIRUS UK LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 11:
12. A method for reducing an elderly subject's incidence of hospitalization for influenza respiratory illness, comprising administering at least a priming, first dose of a tetravalent influenza vaccine adjuvanted with a squalene-containing oil-in-water emulsion to the elderly subject in consecutive influenza seasons, whereby the elderly subject's incidence of hospitalization for influenza respiratory illness is reduced relative to an elderly subject who receives an unadjuvanted influenza vaccine, wherein the elderly subject who receives the adjuvanted tetravalent influenza vaccine is receiving immunosuppressive therapy and ranges from 65-100 years old, and wherein the concentration of squalene in the oil-in-water emulsion ranges from 2 to 10% by weight; further wherein the recipient of the adjuvanted influenza vaccine does not receive an unadjuvanted influenza vaccine during any of the consecutive influenza seasons.